JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Cheesecake Factory
CAKE
$5.13B
| $4.02M | ﹤0.01% |
92,334
+17,047
| +23% | +$826K |
|
|
CRHM
2627
DELISTED
CRH Medical Corporation
CRHM
| $4.01M | ﹤0.01% |
1,315,000
-171,400
| -12% | -$565K |
|
2628
Atkore
ATKR
$2.47B
| $4.01M | ﹤0.01% |
202,086
+37,446
| +23% | +$784K |
|
|
MNTV
2629
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $3.99M | ﹤0.01% |
325,312
+130,193
| +67% | +$1.63M |
|
|
BEST
2630
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $3.99M | ﹤0.01% |
48,551
+48,491
| +80,818% | +$5.04M |
|
2631
ICF International
ICFI
$1.46B
| $3.99M | ﹤0.01% |
61,539
-155,834
| -72% | -$10.9M |
|
2632
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
| $3.99M | ﹤0.01% |
89,481
+15,525
| +21% | +$712K |
|
2633
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.14B
| $3.98M | ﹤0.01% |
53,366
+31,003
| +139% | +$2.31M |
|
2634
Iovance Biotherapeutics
IOVA
$1.83B
| $3.98M | ﹤0.01% |
449,369
+21,137
| +5% | +$204K |
|
|
BKI
2635
DELISTED
Black Knight, Inc. Common Stock
BKI
| $3.97M | ﹤0.01% |
88,176
-42,177
| -32% | -$1.98M |
|
|
FBZ
2636
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $3.97M | ﹤0.01% |
+300,000
| New | +$3.97M |
|
2637
PUT
Akamai
AKAM
$16.7B
| $3.97M | ﹤0.01% |
65,000
| – | – |
|
2638
CALL
Blackrock
BLK
$170B
| $3.97M | ﹤0.01% |
10,100
+6,500
| +181% | +$2.66M |
|
2639
Resideo Technologies
REZI
$5.16B
| $3.97M | ﹤0.01% |
+192,978
| New | +$4.12M |
|
2640
CALL
Target
TGT
$65.6B
| $3.96M | ﹤0.01% |
+60,000
| New | +$4.62M |
|
2641
Simmons First National
SFNC
$3.41B
| $3.96M | ﹤0.01% |
163,930
-30,110
| -16% | -$810K |
|
|
DF
2642
DELISTED
Dean Foods Company
DF
| $3.94M | ﹤0.01% |
1,034,639
-39,270
| -4% | -$237K |
|
2643
Piper Sandler
PIPR
$5.1B
| $3.93M | ﹤0.01% |
238,468
+81,832
| +52% | +$1.43M |
|
2644
iShares US Healthcare ETF
IYH
$3.36B
| $3.92M | ﹤0.01% |
108,475
+15,800
| +17% | +$605K |
|
2645
Greif
GEF
$4.94B
| $3.92M | ﹤0.01% |
105,581
-62,117
| -37% | -$2.91M |
|
2646
Arrowhead Research
ARWR
$12B
| $3.92M | ﹤0.01% |
315,391
+19,630
| +7% | +$268K |
|
2647
RadNet
RDNT
$5B
| $3.91M | ﹤0.01% |
384,572
-100,136
| -21% | -$1.36M |
|
2648
Vanguard Energy ETF
VDE
$9.99B
| $3.91M | ﹤0.01% |
50,705
-26,687
| -34% | -$2.44M |
|
|
RDUS
2649
DELISTED
Radius Health, Inc.
RDUS
| $3.88M | ﹤0.01% |
235,049
+90,117
| +62% | +$1.52M |
|
2650
Ternium
TX
$9.61B
| $3.87M | ﹤0.01% |
142,889
-185,437
| -56% | -$5.53M |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.